← Evidence map

ReviewExpert opinion on biological therapy2017

Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis.

Yahui Grace Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

45 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27871200